JP Morgan Chase
ARDS

JP Morgan Chase’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

JP Morgan Chase’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4
Closed – – 6042
2020
Q3 		$0 Buy
4
+1
+33% +$7 ﹤0.01% 5889
2020
Q2 		$0 Buy
+3
New +$21 ﹤0.01% 5803

Other funds holding ARDS

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase's ARDS Position: Q4 2020 in Review

JP Morgan Chase sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q4 2020, closing a stake of 4 shares.

JP Morgan Chase first reported a position in ARDS in Q2 2020 and held it in 2 quarters. The position peaked at $0 in Q3 2020. 11 funds tracked by Wall St. Rank hold ARDS as of Q4 2020.

  • JP Morgan Chase reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 4 Aridis Pharmaceuticals Inc. Common Stock shares in Q4 2020.
  • JP Morgan Chase first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • JP Morgan Chase's Aridis Pharmaceuticals Inc. Common Stock position peaked at $0 in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.